Trial Profile
ASP1585 Pharmacokinetic Interaction Study - Pharmacokinetic Interaction With Valsartan.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 14 Jan 2020
Price :
$35
*
At a glance
- Drugs Bixalomer (Primary) ; Valsartan
- Indications Diabetic nephropathies; Essential hypertension; Heart failure; Postmyocardial infarction
- Focus Pharmacokinetics
- 26 May 2010 Actual end date (Apr 2010) added as reported by ClinicalTrials.gov.
- 26 May 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 08 May 2010 New trial record